More

• UPDATE 3-U.S. top court says FTC can sue over deals that delay generic drug sales Monday, 17 Jun 2013 | 2:20 PM ET

  WASHINGTON, June 17- The U.S. Supreme Court ruled on Monday regulators can challenge deals between brand-name drug companies and generic rivals that delay cheaper medicines from going on sale, which regulators say increase costs to consumers by billions of dollars.

• UPDATE 1-U.S. justices say FTC can challenge deals to keep generic drugs off market Monday, 17 Jun 2013 | 10:32 AM ET

  WASHINGTON, June 17- The U.S. Supreme Court ruled on Monday that the Federal Trade Commission can challenge deals brand-name drug companies make with generic rivals that keep cheaper products off the market.

• Sector Snap: Makers of morning-after pill rise Thursday, 6 Jun 2013 | 1:47 PM ET

  Shares of Teva Pharmaceutical Industries, which makes Plan B One-Step, increased 41 cents to $38.44 by midday. Shares of Perrigo Co., which has a two-pill pack, jumped nearly 3 percent to $116.47. And Actavis Inc. shares increased 44 cents to $120.78 amid a drop in the broader market.

• UPDATE 2-India's Sun Pharma in talks to buy Sweden's Meda for $5-$6 bln-sources Friday, 31 May 2013 | 11:12 AM ET

  *Meda's most promising asset Dymista allergy inhaler. *Meda shares hit 5-1/ 2- year on news of talks. MUMBAI, May 31- India's Sun Pharmaceutical Industries Ltd is in talks to buy Sweden's Meda AB for between $5 billion and $6 billion to boost its generics business in developed markets, two sources with direct knowledge of the process said.

• UPDATE 3-Canada drugmaker Valeant to buy Bausch & Lomb for $8.7 billion Monday, 27 May 2013 | 1:16 PM ET

  *Valeant shares hit all-time high in Toronto. TORONTO/ WINNIPEG, Manitoba, May 27- Valeant Pharmaceuticals International said on Monday it agreed to buy Bausch& Lomb Holdings Inc from Warburg Pincus LLC for $8.7 billion, a cash deal set to vault the Canadian company into the upper ranks of the global pharmaceutical sector.

• UPDATE 1-Valeant near deal to acquire Bausch & Lomb -source Friday, 24 May 2013 | 1:35 PM ET

  NEW YORK, May 24- Canada's Valeant Pharmaceuticals International is nearing a deal to acquire eye care company Bausch& Lomb Holdings Inc from Warburg Pincus LLC for about $9 billion, a person familiar with the matter said on Friday.

• US STOCKS-Wall St hovers near record levels as investors hesitate to jump in Monday, 20 May 2013 | 2:18 PM ET

  *Yahoo's board approves $1.1 bln Tumblr acquisition. NEW YORK, May 20- U.S. stocks slipped by afternoon trade on Monday as indexes struggled to break above their record levels with investors hesitant to rush into the market.

• GLOBAL MARKETS-Shares grind higher, yen rebounds on minister's remarks Monday, 20 May 2013 | 12:55 PM ET

  Deals such as Yahoo's $1.1 billion bid for Tumblr indicate that companies continue to search for growth through acquisitions despite record high share prices, a bullish sign for stocks.

• US STOCKS-Wall St inches up as deals provide support for rally Monday, 20 May 2013 | 12:50 PM ET

  *Yahoo's board approves $1.1 bln Tumblr acquisition. *Actavis to acquire Warner Chilcott in stock-for-stock deal. Deals, including Yahoo's $1.1 billion bid for Tumblr, indicate that companies continue to search for growth through acquisitions, a bullish sign for stocks.

• US STOCKS-Wall St little changed, deals provide support Monday, 20 May 2013 | 11:07 AM ET

  *Yahoo's board approves $1.1 bln Tumblr acquisition. *Actavis to acquire Warner Chilcott in stock-for-stock deal. Deals including Yahoo's $1.1 billion bid for Tumblr indicate that companies continue to search for growth through acquisitions, a bullish sign for stocks.

• US STOCKS-Wall St dips after records, but deals support Monday, 20 May 2013 | 10:01 AM ET

  *Yahoo's board approves $1.1 bln Tumblr acquisition. *Actavis to acquire Warner Chilcott in stock-for-stock deal. Deals including Yahoo's $1.1 billion bid for Tumblr indicate that companies continue to search for growth through acquisitions despite record highs, a bullish sign for stocks.

• US STOCKS-Wall St to dip after records, acquisitions eyed Monday, 20 May 2013 | 9:17 AM ET

  *Yahoo's board approves $1.1 bln Tumblr acquisition. *Actavis to acquire Warner Chilcott in stock-for-stock deal. Deals including Yahoo's $1.1 billion bid for Tumblr indicate that companies continue to search for growth through acquisitions despite record highs, a bullish sign for stocks.

• Futures Slide Amid Fed Easing Fears Monday, 20 May 2013 | 8:48 AM ET

  U.S. stock market index futures were slightly lower Monday, after major averages finished higher for the fourth-consecutive week, amid ongoing concerns the Federal Reserve may begin to taper off its quantitative easing program sooner than expected.

• US STOCKS-Futures dip after records, acquisitions eyed Monday, 20 May 2013 | 8:30 AM ET

  *Yahoo's board approves $1.1 bln Tumblr acquisition. *Actavis to acquire Warner Chilcott in stock-for-stock deal. Deals including Yahoo's $1.1 billion bid for Tumblr indicate that companies continue to search for growth through acquisitions despite record highs, a bullish sign for stocks.

• Actavis to Buy Warner Chilcott for $8.5 Billion Monday, 20 May 2013 | 8:11 AM ET

  

  Generic drugmaker Actavis will buy specialty pharmaceuticals company Warner Chilcott in a stock deal valued at about $8.5 billion.

• UPDATE 1-Actavis to buy Warner Chilcott in $8.5 billion stock deal Monday, 20 May 2013 | 7:49 AM ET

  May 20- Generic drugmaker Actavis Inc, which has been the subject of intense takeover speculation, said on Monday that it had struck a deal to buy specialty pharmaceuticals company Warner Chilcott Plc for $8.5 billion in stock.

• US STOCKS-Futures little changed after records, acquisitions eyed Monday, 20 May 2013 | 7:43 AM ET

  *Yahoo's board approves $1.1 bln Tumblr acquisition- WSJ. *Actavis to acquire Warner Chilcott in stock-for-stock deal. *Acquisitions including Yahoo's $1.1 billion bid for Tumblr indicate that companies continue to search for growth through acquisitions despite record highs, a bullish sign for the market.

• Actavis to buy Warner Chilcott in $8.5 bln deal Monday, 20 May 2013 | 7:16 AM ET

  Warner Chilcott shareholders will receive 0.160 shares of the combined company, or $20.08 per Warner Chilcott share, based on Actavis's closing share price of $125.50 on May 17.

• Early Movers: WMT, KSS, CSCO & More Thursday, 16 May 2013 | 7:33 AM ET

  

  Some of the names on the move ahead of the open.

• Actavis Rejects $15 Billion Bid From Mylan: Report Wednesday, 15 May 2013 | 7:43 AM ET

  

  Actavis received and rejected a takeover offer from Mylan last week that valued the generic drugmaker at more than $15 billion, a person familiar with the situation said.